J. Finke

发表

Clinical activity of azacitidine in patients who relapse after allogeneic stem cell transplantation for acute myeloid leukemia

J. Bourhis, N. Kröger, C. Craddock, 2016, Haematologica.

Outcome after allogeneic transplantation for adult acute myeloid leukemia patients exhibiting isolated or associated trisomy 8 chromosomal abnormality: a survey on behalf of the ALWP of the EBMT

A. Zander, M. Labopin, J. Finke, 2009, Bone Marrow Transplantation.

Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis

M. Emdin, J. Finke, G. Edan, 2004, Bone Marrow Transplantation.

R. Brand, J. Finke, N. Russell, 2003, Leukemia.

Autologous hematopoietic stem cell transplantation for autoimmune diseases

J. Finke, J. Snowden, A. Gratwohl, 2005, Bone Marrow Transplantation.

Autologous stem cell transplantation in the treatment of systemic sclerosis: report from the EBMT/EULAR Registry

F. Breedveld, P. Emery, J. Finke, 2004, Annals of the rheumatic diseases.

Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency.

H. Einsele, A. Schulz, K. Sullivan, 2015, The Journal of allergy and clinical immunology.

Treosulfan or busulfan plus fludarabine as conditioning treatment before allogeneic haemopoietic stem cell transplantation for older patients with acute myeloid leukaemia or myelodysplastic syndrome (MC-FludT.14/L): a randomised, non-inferiority, phase 3 trial.

C. Hemmelmann, J. Finke, T. Luft, 2019, The Lancet. Haematology.

Long-term follow-up of therapy-related myelodysplasia and AML patients treated with allogeneic hematopoietic cell transplantation

C. Schmoor, J. Finke, R. Wäsch, 2016, Bone Marrow Transplantation.

Bone marrow or peripheral blood stem cell transplantation from unrelated donors in adult patients with acute myeloid leukaemia, an Acute Leukaemia Working Party analysis in 2262 patients

M. Labopin, J. Finke, M. Mohty, 2012, Journal of internal medicine.

Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.

M. Labopin, J. Finke, M. Mohty, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Long-term follow-up of a retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic transplantation from matched related donors in myelodysplastic syndromes

G. Mufti, N. Kröger, M. Robin, 2017, Bone Marrow Transplantation.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

R. Porcher, G. Mufti, C. Craddock, 2017, Bone Marrow Transplantation.

Validation of the revised IPSS at transplant in patients with myelodysplastic syndrome/transformed acute myelogenous leukemia receiving allogeneic stem cell transplantation: a retrospective analysis of the EBMT chronic malignancies working party

G. Mufti, N. Kröger, M. Robin, 2017, Bone Marrow Transplantation.

Prognostic pre-transplant factors in myelodysplastic syndromes primarily treated by high dose allogeneic hematopoietic stem cell transplantation: a retrospective study of the MDS subcommittee of the CMWP of the EBMT

N. Kröger, J. Finke, A. Nagler, 2016, Annals of Hematology.

8. Rodel C, Grabenbauer Gg, Kuhn R Et Al.. Combined-modality Treatment and Selective Organ Preservation in Invasive Bladder Cancer: Long-term Results. Comparing Long-term Toxicity and Efficacy of Combined Modality Treatment including Extended-or Involved-field Radiotherapy in Early-stage Hodgkin's L

H. Eich, R. Müller, V. Diehl, 2022 .

Autologous haematopoietic stem cell transplants for autoimmune disease – feasibility and transplant-related mortality

N. Schmitz, K. Sullivan, P. Brooks, 1999, Bone Marrow Transplantation.

High-dose methotrexate combined with procarbazine and CCNU for primary CNS lymphoma in the elderly: results of a prospective pilot and phase II study.

F. Feuerhake, J. Finke, M. Deckert, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

M. Labopin, J. Finke, J. Snowden, 2016, Bone Marrow Transplantation.

Has Allogeneic Transplantation a Role in the Management of Plasma Cell Leukaemia? A Study on Behalf of the Myeloma Subcomittee of the Chronic Leukaemia Working Party of the EBMT

M. Kersten, S. Iacobelli, G. Gahrton, 2011 .

Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease

K. Sullivan, D. Furst, P. Emery, 2001, Annals of the rheumatic diseases.

The role of genetic variants of NOD2/CARD15, a receptor of the innate immune system, in GvHD and complications following related and unrelated donor haematopoietic stem cell transplantation

G. Rogler, J. Finke, E. Holler, 2008, International journal of immunogenetics.

Conjunctival Epithelial Cells With Donor-Derived Genome After Human Haematopoietic Stem-Cell Transplantation

J. Finke, T. Reinhard, A. Spyridonidis, 2009, Transplantation.

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in adult patients with high-risk or advanced Ewing and soft tissue sarcoma

J. Finke, J. Finke, G. Ihorst, 2006, Journal of Cancer Research and Clinical Oncology.

Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation

H. Putter, N. Kröger, J. Finke, 2017, Bone Marrow Transplantation.

Achievement of complete remission predicts outcome of allogeneic haematopoietic stem cell transplantation in patients with chronic myelomonocytic leukaemia. A study of the Chronic Malignancies Working Party of the European Group for Blood and Marrow Transplantation

A. Ganser, G. Mufti, N. Kröger, 2015, British journal of haematology.

Treatment of systemic sclerosis with autologous haemopoietic stem cell transplantation

J. Winkler, J. Finke, A. Gratwohl, 1997, The Lancet.

Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II Trial

W. Hiddemann, J. Finke, L. Trümper, 2013, Leukemia.

Autologous stem cell transplantation for relapsed/refractory diffuse large B-cell lymphoma: efficacy in the rituximab era and comparison to first allogeneic transplants. A report from the EBMT Lymphoma Working Party

J. Finke, D. Blaise, A. Nagler, 2016, Bone Marrow Transplantation.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

J. Finke, B. Kasenda, G. Illerhaus, 2015, Annals of oncology : official journal of the European Society for Medical Oncology.

Factors predicting outcome after unrelated donor stem cell transplantation in primary refractory acute myeloid leukaemia

C. Craddock, A. Zander, M. Labopin, 2011, Leukemia.

Efficacy of diverse high-dose regimens followed by autologous peripheral blood stem cell transplantation in consecutive multiple myeloma patients: a single-centre analysis over a 12-year period

J. Finke, G. Ihorst, M. Engelhardt, 2006, Annals of Hematology.

Addition of Thiotepa and Rituximab to Antimetabolites Significantly Improves Outcome in Primary CNS Lymphoma: First Randomization of the IELSG32 Trial.

F. Cavalli, R. Soffietti, M. Reni, 2015, Clinical advances in hematology & oncology : H&O.

Reduced-intensity conditioning with fludarabine and thiotepa for second allogeneic transplantation of relapsed patients with AML

C. Schmoor, J. Finke, R. Wäsch, 2013, Bone Marrow Transplantation.

Allogeneic stem cell transplantation for older advanced MDS patients: improved survival with young unrelated donor in comparison with HLA-identical siblings

N. Kröger, M. Robin, J. Finke, 2013, Leukemia.

High-dose chemotherapy and autologous stem cell transplant in elderly patients with primary CNS lymphoma: a pilot study.

J. Finke, F. Scherer, G. Ihorst, 2020, Blood advances.

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

J. Panse, R. Möhle, J. Finke, 2016, Leukemia.

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)

J. Finke, E. Valk, E. Zucca, 2016, BMC Cancer.

Prognosis after high-dose chemotherapy followed by autologous stem-cell transplantation as first-line treatment in primary CNS lymphoma--a long-term follow-up study.

J. Finke, B. Kasenda, G. Illerhaus, 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

German consensus on immunogenetic donor search for transplantation of allogeneic bone marrow and peripheral blood stem cells

N. Schmitz, H. Einsele, W. Friedrich, 1997, Bone Marrow Transplantation.

Transplantation of allogeneic peripheral blood progenitor cells--the EBMT experience.

N. Schmitz, J. Garcia-conde, M. Labopin, 1996, Bone marrow transplantation.

Prognostic factors for survival after allogeneic transplantation in acute lymphoblastic leukemia

J. Finke, J. Duyster, R. Wäsch, 2019, Bone Marrow Transplantation.

Cerebrospinal fluid chimerism analysis in patients with neurological symptoms after allogeneic cell transplantation

J. Finke, J. Duyster, H. Bertz, 2016, Bone Marrow Transplantation.

EBMT prospective observational study on allogeneic hematopoietic stem cell transplantation in T-prolymphocytic leukemia (T-PLL)

W. Wiktor-Jedrzejczak, N. Kröger, S. Iacobelli, 2019, Bone Marrow Transplantation.

Second German consensus on immunogenetic donor search for allotransplantation of hematopoietic stem cells

N. Schmitz, W. Siegert, H. Einsele, 2001, Annals of Hematology.

A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin

J. Finke, J. Duyster, R. Wäsch, 2022, Leukemia & lymphoma.

Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: a population-matched analysis

R. Brand, J. Finke, N. Russell, 2005, Leukemia.

Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT

L. Kanz, M. Labopin, J. Finke, 2017, Bone Marrow Transplantation.

Clofarabine‐containing conditioning regimen for allo‐SCT in AML/ALL patients: a survey from the Acute Leukemia Working Party of EBMT

A. Ganser, M. Labopin, J. Finke, 2011, European journal of haematology.

Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT

R. Porcher, G. Mufti, C. Craddock, 2017, Bone Marrow Transplantation.

Reduced-toxicity conditioning with treosulfan and fludarabine in allogeneic hematopoietic stem cell transplantation for myelodysplastic syndromes: final results of an international prospective phase II trial

H. Einsele, A. Zander, J. Finke, 2011, Haematologica.

Improved outcome with addition of thiotepa and rituximab to methotrexate and cytarabine in primary cns lymphoma: Results of the first randomization of the IELSG-32 trial

A. Ferrer, F. Cavalli, R. Soffietti, 2015 .

A fast and simple approach for the simultaneous detection of hematopoietic chimerism, NPM1, and FLT3-ITD mutations after allogeneic stem cell transplantation

J. Finke, H. Bertz, M. Waterhouse, 2014, Annals of Hematology.

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the chronic leukemia working party of the EBMT

S. Iacobelli, J. Finke, P. Ljungman, 2010, Bone Marrow Transplantation.

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014, Bone Marrow Transplantation.

Conjunctival HLA-DR and CD8 expression detected by impression cytology in ocular graft versus host disease

J. Finke, J. Schwartzkopff, D. Böhringer, 2013, Molecular vision.

Viewpoint: What is the role of allogeneic haematopoietic cell transplantation in the era of reduced-intensity conditioning – is there still an upper age limit? A focus on myeloid neoplasia

J. Finke, A. Nagler, Juergen A. Finke, 2007, Leukemia.

The impact of HLA matching on long-term transplant outcome after allogeneic hematopoietic stem cell transplantation for CLL: a retrospective study from the EBMT registry

R. Brand, J. Finke, N. Russell, 2010, Leukemia.

Polymerase Chain Reaction for the Detection of Chimeric BCR/ABL mRNA in Patients with Chronic Myelogenous Leukemia (CML) — Detection of Minimal Residual Leukemic Cells After Bone Marrow Transplantation

W. Siegert, J. Finke, W. Lange, 1990 .

Alloreactive microenvironment after human hematopoietic cell transplantation induces genomic alterations in epithelium through an ROS-mediated mechanism: in vivo and in vitro study and implications to secondary neoplasia

J. Finke, H. Bertz, A. Spyridonidis, 2010, Leukemia.

Immunogenetic Donor Selection Criteria in Allogeneic Stem Cell Transplantation

H. Einsele, J. Finke, P. Dreger, 2014 .

High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group

M. Pfreundschuh, R. Möhle, J. Finke, 2017, Leukemia.

Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP)

J. Esteve, M. Labopin, J. Finke, 2005, Leukemia.

Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation

J. Finke, P. Dreger, S. Choquet, 2016, Leukemia.

Longitudinal follow-up of nutritional status and its influencing factors in adults undergoing allogeneic hematopoietic cell transplantation

J. Finke, H. Biesalski, H. Bertz, 2013, Bone Marrow Transplantation.

Prophylaxis and treatment of GVHD: EBMT–ELN working group recommendations for a standardized practice

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014, Bone Marrow Transplantation.

Prophylactic donor lymphocyte infusion after allogeneic stem cell transplantation in acute leukaemia – a matched pair analysis by the Acute Leukaemia Working Party of EBMT

J. Esteve, F. Baron, M. Labopin, 2018, British journal of haematology.

Second reduced intensity conditioning allogeneic transplant as a rescue strategy for acute leukaemia patients who relapse after an initial RIC allogeneic transplantation: analysis of risk factors and treatment outcomes

J. Gribben, L. Kanz, M. Labopin, 2016, Bone Marrow Transplantation.

Thiotepa‐based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched‐pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

M. Labopin, J. Finke, A. Nagler, 2017, American journal of hematology.

Impact of conditioning with TBI in adult patients with T-cell ALL who receive a myeloablative allogeneic stem cell transplantation: a report from the acute leukemia working party of EBMT

J. Esteve, M. Labopin, J. Finke, 2016, Bone Marrow Transplantation.

Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience

S. Montoto, J. Finke, S. Dietrich, 2017, Bone Marrow Transplantation.

[Current diagnostics and therapy of B cell Non Hodgkin Lymphoma].

J. Finke, R. Marks, A. Baumgarten, 2012, Therapeutische Umschau. Revue therapeutique.

DNA chimerism and its consequences after allogeneic hematopoietic cell transplantation

J. Finke, A. Spyridonidis, M. Waterhouse, 2011, Chimerism.

Subcutaneous Alemtuzumab (Campath) in Fludarabine-Refractory CLL: Final Results of the CLL2H Trial of the GCLLSG and Comprehensive Analysis of Prognostic Markers

H. Döhner, U. Jäger, J. Finke, 2008 .

A retrospective comparison of autologous and unrelated donor hematopoietic cell transplantation in myelodysplastic syndrome and secondary acute myeloid leukemia: a report on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

R. Brand, J. Finke, D. Niederwieser, 2007, Leukemia.

Interferon- Before Allogeneic Bone Marrow Transplantation in Chronic Myelogenous Leukemia Does Not Affect Outcome Adversely, Provided It Is Discontinued at Least 90 Days Before the Procedure

W. Siegert, H. Heimpel, A. Zander, 1999 .

Geriatric assessment and quality of life in older patients considered for allogeneic hematopoietic cell transplantation: a prospective risk factor and serial assessment analysis

J. Finke, G. Ihorst, B. Deschler, 2018, Bone Marrow Transplantation.

Allogeneic hematopoietic cell transplantation for multiple myeloma in Europe: trends and outcomes over 25 years. A study by the EBMT Chronic Malignancies Working Party

H. Einsele, R. Fanin, N. Kröger, 2016, Leukemia.

Allogeneic stem cell transplantation in acute lymphoblastic leukemia patients older than 60 years: a survey from the acute leukemia working party of EBMT

M. Labopin, J. Finke, A. Nagler, 2017, Oncotarget.

Immunochemotherapy with rituximab, methotrexate, procarbazine, and lomustine for primary CNS lymphoma (PCNSL) in the elderly.

G. Nikkhah, J. Finke, M. Prinz, 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas

M. Engelhard, N. Kröger, J. Finke, 2016, Bone Marrow Transplantation.

Autologous Haematopoietic Stem Cell Transplantation for Crohn’s Disease: A Retrospective Survey of Long-term Outcomes From the European Society for Blood and Marrow Transplantation

J. Satsangi, S. Vermeire, C. Hawkey, 2018, Journal of Crohn's & colitis.

OP021 Autologous haematopoietic stem cell transplantation for Crohn’s disease: a retrospective study from the European Society for Blood & Marrow Transplantation (EBMT) Autoimmune Diseases Working Party

J. Satsangi, S. Vermeire, C. Hawkey, 2018 .

Soluble HLA-G molecules and HLA-G 14-base pair polymorphism after allogeneic hematopoietic cell transplantation.

J. Finke, R. Wäsch, H. Bertz, 2013, Transplantation proceedings.

Allogeneic hematopoietic cell transplantation for t-AML following liver transplantation from the same haploidentical donor

J. Finke, R. Zeiser, H. Bertz, 2009, Bone Marrow Transplantation.

An open, randomized, multicentre study comparing the use of low-dose ceftazidime or cefotaxime, both in combination with netilmicin, in febrile neutropenic patients. German Multicentre Study Group.

J. Finke, R. Pasold, K. Pflüger, 1999, The Journal of antimicrobial chemotherapy.

Body mass index and bioelectrical impedance phase angle as potentially modifiable nutritional markers are independent risk factors for outcome in allogeneic hematopoietic cell transplantation

J. Finke, G. Ihorst, H. Biesalski, 2012, Annals of Hematology.

A wild bootstrap approach for the Aalen–Johansen estimator

Martin Schumacher, Markus Pauly, Tobias Bluhmki, 2018, Biometrics.

Autologous hematopoietic stem cell transplantation for relapsed/refractory systemic anaplastic large cell lymphoma. A retrospective analysis of the lymphoma working party (LWP) of the EBMT

S. Montoto, F. Climent, A. Ganser, 2019, Bone Marrow Transplantation.

An internal validation approach and quality control on hematopoietic chimerism testing after allogeneic hematopoietic cell transplantation

J. Finke, H. Bertz, R. Kunzmann, 2012, Clinical chemistry and laboratory medicine.

High-dose chemotherapy and autologous stem cell transplant compared with conventional chemotherapy for consolidation in newly diagnosed primary CNS lymphoma—a randomized phase III trial (MATRix)

J. Finke, E. Valk, E. Zucca, 2016, BMC Cancer.

Human hematopoietic cell transplantation results in generation of donor-derived epithelial cells

J. Finke, M. Follo, J. Finke, 2005, Leukemia.

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients

J. Finke, G. Ihorst, B. Kasenda, 2019, BMC Cancer.

NOD2/CARD15 polymorphisms in allogeneic stem-cell transplantation from unrelated donors: T depletion matters.

G. Rogler, J. Finke, E. Holler, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Erratum: Prophylaxis and treatment of GVHD: EBMT-ELN working group recommendations for a standardized practice (Bone Marrow Transplantatio (2014) 49 (319) DOI:10.1038/bmt.2013.210)

W. Wiktor-Jedrzejczak, N. Kröger, J. Finke, 2014 .

Comparison of Outcomes After Unrelated Cord Blood Transplantation and Matched Unrelated Donor RIC Transplantation for Lymphoid Malignancies - A Eurocord-Netcord Group/ Lymphoma Working Party and Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation Study.

J. Wagner, J. Finke, D. Blaise, 2009 .

Age-adjusted high-dose chemotherapy and autologous stem cell transplant in elderly and fit primary CNS lymphoma patients

J. Finke, G. Ihorst, B. Kasenda, 2019, BMC Cancer.

Does ex vivo CD34+ positive selection influence outcome after autologous hematopoietic stem cell transplantation in systemic sclerosis patients?

M. Labopin, J. Finke, J. Snowden, 2016, Bone Marrow Transplantation.

Impact of the intensity of conditioning regimen in 144 patients with follicular lymphoma (FL) receiving a matched unrelated donor stem cell transplant (MUD-SCT): An analysis from the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation (LWP-EBMT)

S. Montoto, G. Mufti, H. Tilly, 2008 .

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

R. Brand, J. Finke, N. Russell, 2008 .